Joan Genescà Ferrer Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine. Institutions of which they are part Head of group Liver Diseases Vall Hebron Institut de Recerca Hepatologia General Hospital Twitter Orcid Email Joan Genescà Ferrer Twitter Orcid Email Institutions of which they are part Head of group Liver Diseases Vall Hebron Institut de Recerca Hepatologia General Hospital Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.
Projects Malalties Hepatobiliars (GRC) IP: - Collaborators: Beatriz Minguez Rosique, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Antonio González Fernández, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Malalties Hepatobiliars (GRC), Silvia Sauleda Oliveras, Maria Buti Ferret, Josep Quer Sivila, Josep Gregori Font, Malalties Hepatobiliars (GRC), Damir Garcia Cehic, Juan Ignacio Esteban Mur, Meritxell Ventura Cots, Macarena Simon-Talero Horga, Joan Genescà Ferrer, David Tabernero Caellas Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 65000 Reference: 2014 SGR 421 Duration: 01/01/2014 - 31/12/2016 Nuevos tratamientos combinados en distintas fases de la cirrosis hepática con hipertensión portal IP: Joan Genescà Ferrer Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 30000 Reference: INT14/00113 Duration: 20/05/2015 - 19/05/2016 Papel de la elastografía hepática y esplénica en el diagnóstico, seguimiento y tratamiento de la enfermedad crónica hepática avanzada. IP: Joan Genescà Ferrer Collaborators: Mònica Pons Delgado Funding agency: Instituto de Salud Carlos III Funding: 82400 Reference: FI14/00152 Duration: 01/01/2015 - 31/12/2018 Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis Molecular Subtypes for Targeted Therapies in Alcoholic Hepatittis U01 AA021908-01 IP: - Collaborators: Joan Genescà Ferrer Funding agency: National Institutes of Health (NIH) Funding: 94320 Reference: INTEAM_NIH-NIAAA2013 Duration: 01/06/2013 - 31/12/2018 Pagination First page « Previous page ‹ … Page 6 Page 7 Current page 8 Page 9 Page 10 … Next page › Last page »
